Company is advancing portfolio of novel therapies that aim to redefine the standard of care for patients with autoimmune diseases Lead candidate JADE-001 on track to enter the clinic in second half of 2025, with initial data expected in first half of 2026 The combined company will operate as “Jade Biosciences, Inc.” and will trade on Nasdaq under the ticker symbol “JBIO” SAN FRANCISCO and VANCOUVER, British Columbia, April 28, 2025 (GLOBE NEWSWIRE) — Jade Biosciences, Inc. (“Jade” or the “Company”), a biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced the completion of its previously announced merger with Aerovate Therapeutics, Inc. (“Aerovate”). The combined company will operate as Jade Biosciences, Inc., with its shares expected to begin trading on the Nasdaq Capital...

Acquisition Establishes Clinical and Operational Foundation for LifeMD’s Comprehensive Women’s Health Offering, Launching Summer 2025 NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) — LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced the acquisition of key assets from Optimal Human Health MD (“Optimal”), a nationwide women’s health virtual care provider. This strategic acquisition marks LifeMD’s official entry into the women’s health market and establishes a scalable clinical foundation for a comprehensive virtual health program under the LifeMD brand, focused on hormone health, bone density, metabolism, and long-term wellness. With women’s health historically underserved—particularly in areas such as perimenopause, menopause, and hormonal balance—LifeMD’s expansion addresses a significant...

Acquisition of approximately 71% stake in Kokomodo Ltd. Acquisition uniquely combines Pluri’s mass-scale cell production expertise with Kokomodo Ltd.’s ability to craft real, controlled, climate-resilient cacao using cellular agriculture technologyHAIFA, Israel, April 28, 2025 (GLOBE NEWSWIRE) — Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”), a leading biotechnology company leveraging its proprietary platform for cell-based solutions to create a collaborative network of ventures, today announced the completion of the acquisition of approximately 71% of the equity of Kokomodo Ltd. (“Kokomodo”), an innovative AgFoodTech company specializing in cultivated cacao production, for $4.5 million payable in 976,139 of the Company’s Common Shares (the “Common Shares” and the “Kokomodo Transaction”, respectively)....

FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)        Name of exempt principal trader: Shore Capital Stockbrokers Ltd(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree Anexo Group Plc(c)        Name of the party to the offer with which exempt principal trader is connected: Anexo Group Plc(d)        Date dealing undertaken: 24 April 2025(e)        Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer? No2.        DEALINGS BY THE EXEMPT PRINCIPAL TRADER (a)        Purchases and salesClass...

– Purchase price of $47 per share in cash represents an equity value of approximately $3.9 billion, or an enterprise value of $3.4 billion (€3.0 billion) – – Planned acquisition will immediately add revenue and accelerate mid- to long-term growth for Merck KGaA, Darmstadt, Germany’s Healthcare business – – SpringWorks Therapeutics is a U.S. biopharmaceutical company with a first-in-class, systemic standard-of-care therapy in adults with desmoid tumors and the first and only approved therapy for adults and children with neurofibromatosis type 1-associated plexiform neurofibromas – – Planned acquisition will strengthen the presence of Merck KGaA, Darmstadt, Germany’s Healthcare business in the United States and expand reach of SpringWorks’ therapeutic innovations to more patients with rare tumors worldwide – STAMFORD, Conn., April...

Merger of Equals Increases Scale and Benefits All ShareholdersCreates powerful platform underpinned by a shared vision for growth. Three cash-generating mines in premier mining jurisdictions with strong organic growth. Projected gold equivalent production of ~160,0001 ounces in 2025, increasing to over ~180,0002 ounces in 2026. Robust proforma balance sheet: A$188 / C$167 million cash to fuel growth as at 31 March 20253. Increased scale and trading liquidity anticipated to drive valuation re-rate.PERTH, Australia and TORONTO, April 27, 2025 (GLOBE NEWSWIRE) — Alkane Resources Limited (ASX: ALK) (“Alkane”) and Mandalay Resources Corporation (“Mandalay”) (TSX: MND, OTCQB: MNDJF) are pleased to announce that they have agreed to combine in a “merger of equals” transaction and have executed a definitive arrangement agreement (the...

Texas-based commercial lines agency adds to construction, manufacturing, and energy industry expertise BOSTON, April 27, 2025 (GLOBE NEWSWIRE) — Risk Strategies, a leading North American specialty insurance brokerage, risk management and consulting firm, announced today that it has acquired GMC Advisors, LLC., based in Houston. Terms of the deal were not disclosed. Headed by owner Greg Chubon, GMC Advisors is a specialist in commercial lines insurance products, with a focus on the construction and manufacturing industries, as well as companies in the energy sector. Founded in 2003, the firm has built a record of consistent growth propelled by specialty knowledge and a focus on helping middle-market companies in target industries. “It is great to add such deep industry expertise to our West Region as we continue to build out our...

TORONTO, April 25, 2025 (GLOBE NEWSWIRE) — Martina Minerals Corp. (the “Company”) (TSXV: MTN.H) is pleased to announce that it has entered into a non-binding letter of intent (the “LOI”) on April 24, 2025, with 7303 Warden Inc. (“7303”), a non-arm’s length party, pursuant to which the Company intends to acquire (the “Acquisition”) all of the issued and outstanding securities of 7303 by way of share exchange, three cornered amalgamation or other acceptable means, subject to regulatory approval including that of the TSX Venture Exchange (the “Exchange”). Upon completion of the Acquisition, subject to all requisite approvals, it is anticipated that the Resulting Issuer (as defined herein) will be a Tier 1 – Industrial issuer. About 7303 7303 located at 7303 Warden Avenue in Markham, Ontario, is at the forefront of technology...

Global InterConnection Group announces the Approval of Convertible Loan Note Amendments following Agreement of the Atlantic SuperConnection Spin-Out and Supporting Right of First Refusal Process. Please see the full press release attached.AttachmentRight of First Refusal for CLN investment

TAMPA, Fla., April 25, 2025 (GLOBE NEWSWIRE) — Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, today announced the closing of its business combination with SRx Health Solutions, Inc. (‘SRx Health’) and the closing of an $8.8 million private placement with an institutional investor, for the purchase and sale of a combination of 4,036,697 shares of common stock and pre-funded warrants at a price of $2.18 per share for aggregate gross proceeds of $8.8 million, before deducting offering expenses. Better Choice will issue 28.6 million shares of common stock in connection with the closing of the business combination with SRx Health, pursuant to which the combined company will emerge as a leading global health and wellness company by providing better products and...